Ingrid Atteryd Heiman

Insider profile

Currently holds positions in Doxa AB, Dignitana AB and Herantis Pharma Oyj

Positions

Position Company Period
Chairman of the Board Doxa AB May 31, 2018 -
Director Dignitana AB March 16, 2018 -
Director Herantis Pharma Oyj March 12, 2019 -
Executive Chairman of the Board Ellen AB April 10, 2017 - Sept. 17, 2018
Director Doxa AB June 11, 2015 - May 31, 2018
Director Aino Health AB (publ) Jan. 1, 2016 - May 16, 2017
Chairman of the Board Ellen AB April 4, 2015 - April 10, 2017
Director Ellen AB Feb. 6, 2015 - April 4, 2015
Acting Chief Executive Officer, Director Ellen AB Feb. 12, 2014 - Feb. 6, 2015
Director Ellen AB April 19, 2012 - Feb. 12, 2014
Ingrid Atteryd Heiman's trades of Doxa AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
SE Doxa AB (DOXA)
Transaction date
Purchase
Price
473.21
Quantity 36,305
Value SEK1,135,984
SE Doxa AB (DOXA)
Transaction date
Purchase
Price
369.53
Quantity 49,289
Value SEK3,165,491
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-10-01 2019-09-30
SE Doxa AB (DOXA)
B Purchase
36,305
473.21
SEK1,135,984 		36,305 473.21 SEK1,135,984
2019-09-30 2019-09-30
SE Doxa AB (DOXA)
B Purchase
49,289
369.53
SEK3,165,491 		49,289 369.53 SEK3,165,491